QUINALAN Drug Patent Profile
✉ Email this page to a colleague
When do Quinalan patents expire, and when can generic versions of Quinalan launch?
Quinalan is a drug marketed by Chartwell Molecular and is included in one NDA.
The generic ingredient in QUINALAN is quinidine gluconate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the quinidine gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Quinalan
A generic version of QUINALAN was approved as quinidine gluconate by SUN PHARM INDUSTRIES on February 11th, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for QUINALAN?
- What are the global sales for QUINALAN?
- What is Average Wholesale Price for QUINALAN?
Summary for QUINALAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 24 |
| Patent Applications: | 1,734 |
| DailyMed Link: | QUINALAN at DailyMed |
US Patents and Regulatory Information for QUINALAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Molecular | QUINALAN | quinidine gluconate | TABLET, EXTENDED RELEASE;ORAL | 088081-001 | Feb 10, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
